Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.42)
# 1,149
Out of 5,051 analysts
327
Total ratings
41.9%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRZN Surrozen | Maintained: Buy | $40 | $29.69 | +34.73% | 4 | Oct 12, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $7 | $3.77 | +85.68% | 9 | Sep 28, 2026 | |
| LXRX Lexicon Pharmaceuticals | Initiated Coverage: Buy | $8 | $1.68 | +376.19% | 1 | Sep 28, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $15 | $4.65 | +222.58% | 6 | Sep 10, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $46 → $65 | $31.10 | +109.00% | 7 | Sep 9, 2026 | |
| INVA Innoviva | Reiterated: Buy | $34 | $21.21 | +60.30% | 7 | Aug 20, 2026 | |
| EYPT EyePoint | Downgraded: Hold | n/a | $3.40 | - | 3 | Aug 17, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $266 → $270 | $154.49 | +74.77% | 4 | Aug 14, 2026 | |
| EQ Equillium | Reiterated: Buy | $10 | $1.41 | +609.22% | 2 | Aug 14, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $8 | $1.63 | +390.80% | 12 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $28.51 | +250.75% | 35 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $29.36 | +199.73% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $24.63 | +78.64% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.34 | +274.53% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $6 | $1.60 | +275.00% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $10.16 | +116.54% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $12 | $12.55 | -4.34% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $8.55 | +239.18% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 33.00 | kr 9.00 | +266.67% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $13 | $3.46 | +275.72% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.03 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥302 | +274.17% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $21.58 | +127.11% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $232.68 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $8.34 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $103 | $151.17 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.90 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $17 | $4.00 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $51 | $82.37 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $56 | $16.64 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $77 | $86.01 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $17 | $2.94 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $78 | $13.07 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $35 | $2.56 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $112.40 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $471.75 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $5 | $9.31 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $45.95 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $13.74 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.04 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $225.71 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $53.39 | n/a | 12 | Jun 13, 2021 |
Surrozen
Oct 12, 2026
Maintained: Buy
Price Target: $40
Current: $29.69
Upside: +34.73%
Camp4 Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.77
Upside: +85.68%
Lexicon Pharmaceuticals
Sep 28, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.68
Upside: +376.19%
Opus Genetics
Sep 10, 2026
Reiterated: Buy
Price Target: $15
Current: $4.65
Upside: +222.58%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $46 → $65
Current: $31.10
Upside: +109.00%
Innoviva
Aug 20, 2026
Reiterated: Buy
Price Target: $34
Current: $21.21
Upside: +60.30%
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.40
Upside: -
Belite Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $266 → $270
Current: $154.49
Upside: +74.77%
Equillium
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
ProQR Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $1.63
Upside: +390.80%
Aug 14, 2026
Reiterated: Buy
Price Target: $100
Current: $28.51
Upside: +250.75%
Aug 10, 2026
Reiterated: Buy
Price Target: $88
Current: $29.36
Upside: +199.73%
Aug 10, 2026
Reiterated: Buy
Price Target: $44
Current: $24.63
Upside: +78.64%
Aug 6, 2026
Reiterated: Buy
Price Target: $20
Current: $5.34
Upside: +274.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $1.60
Upside: +275.00%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $10.16
Upside: +116.54%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $12.55
Upside: -4.34%
Jun 30, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $8.55
Upside: +239.18%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 9.00
Upside: +266.67%
May 18, 2026
Reiterated: Buy
Price Target: $34 → $13
Current: $3.46
Upside: +275.72%
Apr 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.03
Upside: -
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥302
Upside: +274.17%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $21.58
Upside: +127.11%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $232.68
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $22
Current: $8.34
Upside: n/a
Nov 8, 2024
Reiterated: Buy
Price Target: $93 → $103
Current: $151.17
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.90
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $22 → $17
Current: $4.00
Upside: n/a
Apr 18, 2024
Reiterated: Buy
Price Target: $24 → $51
Current: $82.37
Upside: n/a
Jan 3, 2024
Reiterated: Buy
Price Target: $27 → $56
Current: $16.64
Upside: n/a
Oct 18, 2023
Reiterated: Buy
Price Target: $84 → $77
Current: $86.01
Upside: n/a
Jun 23, 2023
Reiterated: Buy
Price Target: $25 → $17
Current: $2.94
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $94 → $78
Current: $13.07
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $33 → $35
Current: $2.56
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $112.40
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $471.75
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: $15 → $5
Current: $9.31
Upside: n/a
Nov 9, 2022
Reiterated: Buy
Price Target: $38
Current: $45.95
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $13.74
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $18
Current: $7.04
Upside: n/a
Jul 22, 2021
Reiterated: Hold
Price Target: n/a
Current: $225.71
Upside: n/a
Jun 13, 2021
Reiterated: Sell
Price Target: n/a
Current: $53.39
Upside: n/a